Peri-Implantitis Treatment Market Is Estimated To Register CAGR 8% During The Forecast Period 2022-2031

(MENAFN- America News Hour) Research Nester published a report titled
peri-implantitis treatment market : Global Demand Analysis & Opportunity Outlook 2031”
which delivers detailed overview of the global peri-implantitis treatment market in terms of market segmentation by type, end-user, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global peri-implantitis treatment market is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2022 – 2031. The market is bifurcated by type into surgical and non-surgical, out of which the surgical segment is estimated to hold the largest share in the market over the forecast period, owing to the quicker treatment process, immediate relief and higher success rate of surgeries. Moreover, the surgical segment is sub segmented into bone regeneration, open flap debridement, and implantoplasty.

The global peri-implantitis treatment market is estimated to grow on the back of the poor oral health, and high prevalence of periodontal diseases, which lead to higher demand for dental implants. Peri-implantitis is caused due to infection in the dental implants, which can cause inflammation of gums, pain, and a feeling of the implant becoming loose. The growing oral health awareness amongst the people is estimated to boost the demand for treatment for peri-implantitis. Further, the increasing healthcare expenditure across the globe is estimated to boost the market growth.

On the basis of geographical analysis, the global peri-implantitis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the growing incidences of oral diseases, combined with availability of advanced treatment methods in the region.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players' competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Increasing Prevalence of Oral Diseases to Boost the Market Growth

According the data by the World Health Organization (WHO), almost 10% of the global population is affected with severe periodontal (gum) disease, which may result in tooth loss.

The growing cases of oral diseases that lead to the need for dental implants, is majorly estimated to boost the market growth. Additionally, people are more aware regarding their oral health, which is estimated to increase the demand for treatment for peri-implantitis. Such factors are estimated to boost the market growth.

However, lack of awareness about peri-implantitis, and its difficult diagnosis expected to operate as key restraint to the growth of global peri-implantitis treatment market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global peri-implantitis treatment market which includes company profiling of Pfizer Inc., Cadila Pharmaceuticals, R.N. Laboratories Pvt. Ltd., Neoss Limited, Basic Pharma Life Science Pvt. Ltd., Dawood and Tanner, Prachi Pharmaceuticals Private Limited, Geistlich Pharma Inc., Healthy Life Pharma Pvt. Ltd, and Aetna Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global peri-implantitis treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Curious about this latest version of report? Obtain Report Details @

About Research Nester

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.


America News Hour

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.